Quantcast

Latest Ranbaxy Laboratories Stories

2009-03-05 10:09:00

PRINCETON, N.J., March 5 /PRNewswire/ -- Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that RLL has received approval from the U.S. Food and Drug Administration to manufacture and market Quinapril Hydrochloride & Hydrochlorothiazide (Quinapril + HCTZ) Tablets, 10mg/12.5mg, 20mg/12.5mg and 20mg/25mg. The Application for the drug was submitted by Ranbaxy, from its Ohm Laboratories manufacturing facility located in...

2009-02-25 14:23:00

GURGAON, India, Feb. 25 /PRNewswire/ -- Ranbaxy has just received a letter and information indicating that all pending and approved ANDAs from Ranbaxy's Paonta Sahib facility have been added to a list maintained under a policy entitled "Application Integrity Policy" or "AIP". Ranbaxy will analyze the letter and other information fully and respond appropriately in a timely manner. The FDA has said it has no evidence the drugs on the market are substandard and also that they comply with...

2009-02-25 11:19:38

The U.S. Food and Drug Administration says it is taking new regulatory action against Ranbaxy Pharmaceuticals Inc.'s Paonta Sahib plant in India. The FDA said it has halted the review of drug applications from the plant, accusing officials of falsifying data and test results in approved and pending drug applications. The facility has been under an FDA import alert since September. The federal agency said it is continuing to investigate this matter to ensure the safety and efficacy of marketed...

2008-11-11 00:00:27

Research and Markets (http://www.researchandmarkets.com/research/9681f0/india_pharmaceutic) has announced the addition of the "India Pharmaceutical Regulatory Report 2008 (with appendix)" report to their offering. The India Pharmaceutical Regulatory Report comprehensively covers all aspects of pharmaceutical regulations in India. It includes overviews of the laws and procedures on registration, manufacturing, distribution, price control, marketing, research and development, and...

2008-10-31 09:00:27

Research and Markets (http://www.researchandmarkets.com/research/45cca1/indian_pharmaceuti) has announced the addition of the "Indian Pharmaceutical Industry" report to their offering. The Indian pharmaceutical industry grew at 13% during 2003-2007, driven by rising consumption levels in the country and strong demands from export markets. In 2006-07, the Indian pharma market reached US 8.16 billion and is estimated to reach US 9.77 billion in 2007-08. At present, India's pharmaceutical...

2008-10-03 09:00:37

Research and Markets (http://www.researchandmarkets.com/research/6d2dfc/japan_pharmaceutic) has announced the addition of the "Japan Pharmaceuticals and Healthcare Report Q3 2008" report to their offering. BMI's Japan Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on Japan's pharmaceuticals and healthcare industry. Japan has the second largest pharmaceutical market in the world, currently valued at approximately US$76bn. Using BMI's...

2008-09-19 09:00:41

Research and Markets (http://www.researchandmarkets.com/research/a4c187/romania_pharmaceut) has announced the addition of the "Romania Pharmaceuticals and Healthcare Report Q3 2008" report to their offering. Our Romania Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on Romania's pharmaceuticals and healthcare industry. In our adjusted Business Environment Rankings for Central & Eastern Europe (CEE) for Q308, Romania is found in...

2008-09-17 18:00:07

By The Associated Press WASHINGTON - The government is closing U.S. borders to more than 30 generic drugs - including popular antibiotics and cholesterol medicines - made by India's drug giant Ranbaxy Laboratories because of poor quality in two of its factories. The Food and Drug Administration says consumers who already have the drugs shouldn't worry: Repeated testing hasn't found any contamination, and Ranbaxy can continue selling medicines made at any of its other factories. The...

dd0772b310f9cf6dd7248b15c0b8292f1
2008-09-17 15:25:00

The U.S. Food and Drug Administration initiated a block on Tuesday of more than 30 generic drugs produced by Ranbaxy Laboratories Ltd. "“ India's biggest pharmaceutical company. The FDA said two of the pharmaceutical company's factories were in poor shape. The block includes generic versions of popular drugs including Cipro and cholesterol pill Zocor. Earlier this year, FDA inspections revealed violations that could be linked to contamination, allergic reactions and other complications...

2008-09-17 12:00:35

The FDA has issued two warning letters to India-based Ranbaxy Laboratories, and an import alert for generic drugs produced by the company's Dewas and Paonta Sahib plants in India. The warning letters identify the agency's concerns about deviations from US current Good Manufacturing Practice (cGMP) requirements at Ranbaxy's manufacturing facilities in Dewas and Paonta Sahib (including the Batamandi unit), in India. The problems at these two Ranbaxy plants relate to deficiencies in the...


Word of the Day
tesla
  • The unit of magnetic flux density in the International System of Units, equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.
This word is named for Nikola Tesla, the inventor, engineer, and futurist.